SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001387131-12-000342
Filing Date
2012-02-14
Accepted
2012-02-14 17:01:56
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT ohr_10qa-123111.htm 10-Q/A 676863
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 15452
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 16020
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 7459
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 7769
  Complete submission text file 0001387131-12-000342.txt   2046719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ohrp-20111231.xml EX-101.INS 174351
7 XBRL SCHEMA FILE ohrp-20111231.xsd EX-101.SCH 12994
8 XBRL CALCULATION FILE ohrp-20111231_cal.xml EX-101.CAL 28359
9 XBRL DEFINITION FILE ohrp-20111231_def.xml EX-101.DEF 7036
10 XBRL LABEL FILE ohrp-20111231_lab.xml EX-101.LAB 111572
11 XBRL PRESENTATION FILE ohrp-20111231_pre.xml EX-101.PRE 71869
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-88480 | Film No.: 12612178
SIC: 2834 Pharmaceutical Preparations